Sterol O-acyltransferase 1 (SOAT1) is an endoplasmic reticulum (ER) resident, multi-25 transmembrane enzyme that belongs to the membrane-bound O-acyltransferase (MBOAT) 26 family 1 . It catalyzes the esterification of cholesterol to generate cholesteryl esters for cholesterol 27 storage 2 . SOAT1 is a target to treat several human diseases 3 . However, its structure and 28 mechanism remain elusive since its discovery. Here, we report the structure of human SOAT1 29 (hSOAT1) determined by cryo-EM. hSOAT1 is a tetramer consisted of a dimer of dimer. The 30 structure of hSOAT1 dimer at 3.5 Å resolution reveals that the small molecule inhibitor CI-976 31 binds inside the catalytic chamber and blocks the accessibility of the active site residues H460, 32 N421 and W420. Our results pave the way for future mechanistic study and rational drug design 33 of SOAT1 and other mammalian MBOAT family members. 34 35 36 37 38 39 40 41 42 43 44 45 46 Main 47
and oleoyl-CoA as substrates based on the previously reported SOAT1 whole cell assay 20 (Fig. 93 1a and Fig. S1c-h) . The results show that the activity of hSOAT1 tetramer is linear within the 94 first 15 min (Fig. S1h) , and both the purified tetramer and dimer hSOAT1 protein exhibited 95 cholesterol-activated O-acyltransferase activity in detergent micelles (Fig. 1b, Fig. S1d-h) . 96
Moreover, the SOAT enzyme activity is inhibited by CI-976 in a dose-dependent manner (Fig.  97 1c). 98
To investigate the structure of hSOAT1, we prepared the sample of hSOAT1 in the presence of 99 CI-976 in detergent micelles for cryo-EM analysis. The 3D classification showed the hSOAT1 100 protein exhibited severe conformational heterogeneity ( Fig. S2 ). One of the 3D classes can be 101 further refined to 12 Å and the map allowed the visualization of the general shape of hSOAT1, in 102 which the cytosolic N terminal oligomerization domain lays above the transmembrane domain. 103
Moreover, the central slice of the transmembrane domain density map indicated the hSOAT1 is a 104 tetramer composed of dimer of dimers ( Fig. S2d) , which is consistent with previous biochemical 105 data 19 . To further stabilize the transmembrane domain, we reconstituted hSOAT1 into a lipid 106 nanodisc ( Fig. S3a, S3b ) for cryo-EM analysis (Fig. S4 ). The top view of 2D class averages of 107 the nanodisc sample had markedly enhanced features and confirmed the transmembrane region 108 of hSOAT1 to be a dimer of dimers ( Fig. S4b ). However, some 2D class averages in top views 109 showed that one distinct dimer was adjacent to another blurry but still distinguishable dimer (Fig. 110 S4b), suggesting the dimer-dimer interface is mobile. Through multiple rounds of 2D and 3D 111 classification, two 3D classes with discernable transmembrane helix densities were isolated. 112 Subsequent refinements generated reconstructions at resolutions of 8.2 Å (for the oval-shaped 113 tetramer) and 7.6 Å (for the rhombic-shaped tetramer) ( Fig. S4c, S4d ). The oval-shaped structure 114 occupies a 3D space of 170 Å×120 Å×50 Å and the shape is similar to 3D Class 1 observed in 115 detergent micelles (Fig. S2) , and the rhombic-shaped structure occupies 185 Å×110 Å×50 Å 116 ( Fig. 2) , similar to the 3D Class 2 observed in detergent micelles (Fig. S2 ). The N terminal 117 tetramerization domain is invisible in both maps probably due to its flexibility. These two 118 structures reveal that the dimer-dimer interfaces of oval-shaped and rhombic-shaped hSOAT1 119 are distinct ( Fig. 2b, d) , correlating with the 3D heterogeneity observed in detergent micelles. 120
This suggests the interfaces between dimers are unstable and dynamic in nature, which in turn 121 hampered high-resolution structure determination. To overcome the conformational 122 heterogeneity in the tetrameric hSOAT1 sample, the functional dimer construct (hSOAT1 66-123 550) was expressed and purified. The protein was reconstituted into the nanodisc in the presence 124 of inhibitor CI-976 ( Fig. S3c, S3d ). Subsequent 3D reconstruction generated a 3.5 Å cryo-EM 125 which is capped by the cytosolic helices αC, αD, and αE on the top. At the end of M9, a C-139 terminal ER luminal loop (CT loop) is cross-linked by the disulfide bond formed between C528 140 and C546 ( Fig. 3d ). It was previously reported that this loop is important for hSOAT activity and 141 stability 22,23 . Indeed, the CT loop interacts with both the luminal M7-M8 loop and the M5-M6 142 loop ( Fig. 3d ) at the ER luminal side. Based on the sequence homology ( Fig. S7 ), the closely 143 related SOAT2 and the distal related DGAT1 enzymes might have a similar transmembrane 144 domain topology to hSOAT1 reported here. In addition, the TM2-9 of hSOAT1 share a similar 145 structural fold with H4-H16 of DltB 16 , with core RMSD of 3.2 Å for 227 structurally aligned 146 residues, despite of their low sequence identity ( Fig. 3e ), suggesting a common evolutionary 147 origin of the MBOAT family enzymes. 148 149
Dimer interface 150
In contrast to the monomeric DltB protein, the functional unit of hSOAT1 is a tightly packed 151 dimer, with a dimer interface area of 6,520 Å 2 . The two hSOAT1 protomers interact through the 152 M1, M6, M6-αD loop and M9 helices in a symmetric way ( Fig. 4a and b ). In the inner leaflet of 153 the ER membrane, M144, A147, L148 and L151 on M1 of one subunit interact with I370 and 154 F378 on M6, and V501, W504 and F508 of M9 of the other subunit ( Fig. 4c and d ). In the outer 155 leaflet of ER membrane, V158 and V159 on M1 interact with V363 on M6 of the other subunit 156 ( Fig. 4c and d ). The residues that form the dimer interface are mostly hydrophobic and interact 157 with each other in a shape-complementary manner. 158 159
Reaction chamber of hSOAT1
Previous studies suggest that the conserved H460 on M7 is crucial for hSOAT1 activity and is 161 the putative catalytic residue 21 . The side chain of H460 points towards the interior of the central 162 cavity cradled by M4M9 ( Fig. 5a and b ). These structural observations suggest this central 163 cavity is the chamber where the acyl transfer reaction takes place. In accordance with this, 164 previous studies have also identified several residues in the central cavity that are important for 165 hSOAT1 function. Mutations of residues on M7 and M8 affect the catalytic activity 24, 25 . C467 at 166 the end of M7 is the major target site for p-chloromercuribenzene sulfonic acid-mediated SOAT1 167 inactivation 26 . These data also indicate that the local environment in the central cavity is 168 important for the catalytic reaction. 169
The reaction chamber is covered by a lid formed by M4-αC loop, αC, M6-αD loop, αD and αE 170 on the cytosolic side. It is suggested that part of the cytosolic lid, residues 403-409 on M6-αD 171 loop, may be involved in the binding of fatty acyl-CoA 27 . To further explore the role of the 172 residues in this region, we performed alanine or cysteine mutagenesis of conserved residues 173 within region amino acids 406-422 (from M6-αD loop to αD, Fig. 5c ), and analyzed the effects 174 of mutations after transient expressions of each of these mutant plasmid DNAs in a CHO cell 175 clone AC29, that is devoid of endogenous SOAT activity, but regains enzyme activity upon 176 transient expression of hSOAT plasmid DNA 28 . The results showed that mutating any of the 177 following residues W407, S414, Y416, Y417, R418, W420, and N421 to alanines or cysteines 178 caused loss in normalized hSOAT1 enzyme activity (by greater than 90%) without severely 179 lowering the cellular hSOAT1 protein expression in transfected cells ( Fig. 5d ). Because the 180 hydrophilic side chains of S414 and R418 on αD face the cytosolic side of SOAT1, S414 and 181 R418 might be involved in functions important for hSOAT1 activity, such as binding of highly 182 hydrophilic CoA group of fatty acyl-CoA substrate. These results further emphasize the 183 important role of the cytosolic lid of the reaction chamber in the enzymatic reaction. 184 185
Inhibitor and ligands binding sites 186
A strong extra non-protein density was found in the central cavity and the size and shape of the 187 density matched that of the inhibitor CI-976, which was included during cryo-EM sample 188 preparation ( Fig. S8a) . By comparing the current map with the maps without CI-976 (as 189 described later), we proposed that this "nonprotein material" represents the CI-976 molecule. 190
The large trimethoxyphenyl group of CI-976 is sandwiched between the catalytic residue H460 191 on M7, and residues N421 as well as W420 on the αD-αE loop ( There are several extra non-protein densities observed in the cryo-EM map. One density (density 200 A) is close to the dimer interface. It is surrounded by L129, L132 and L133 on the hydrophobic 201 side of αA, F145 on M1, C333 on M5, F382 on M6 and W408 on M6-αD loop (Fig. S8c ). The 202 shape of this density is close to cholesterol, suggesting this ligand might be a tightly-bound 203 sterol-like molecule that was carried on during membrane protein extraction and purification. 204
SOATs are allosteric enzymes that can be activated by cholesterol 3 and it is predicted that 205 SOATs have two functional distinct cholesterol binding sites. One site is the substrate binding 206 site and the other is the allosteric activating site that provides the feedback regulation mechanism 207 regarding cholesterol concentration in the ER 3 . On the other hand, previous work showed that 208 SOAT1 exhibits only low affinity binding towards cholesterol, either as substrate or as activator, 209 with dissociation constant at sub-millimolar concentration 30 . Therefore, we speculate that the 210 molecule in density A is neither a cholesterol substrate nor a cholesterol activator, but a sterol- In order to gain more mechanistic insights into the catalytic mechanism of hSOAT1 and to trap 218 the catalytic reaction in a transition state, we designed and synthesized a compound that might 219 mimic the catalytic transition intermediate. Inspired by the previous work on GOAT 31 , we 220 hypothesized that the catalytic reaction intermediate of hSOAT1 might be a ternary complex of 221 sterol, acyl-CoA and the enzyme. Therefore, the covalent linkage of sterol and acyl-CoA would 222 yield a competitive inhibitor with a higher affinity than each individual substrate alone. 223
Pregnenolone was previously reported to be a substrate of hSOAT1 with a lower K m and better 224 solubility than cholesterol 32 . In the current study, CoA group was chemically covalently linked 225 with stearoyl-pregnenolone to generate a bi-substrate analogue for hSOAT1 (BiSAS) ( Table S1 ). This map was compared with the CI-976 bound map and was found to be 230 similar overall, with a real space correlation of 0.9. We anticipated that BiSAS might mimic both 231 substrates of hSOAT1 and might occupy the substrate-binding pocket while cholesterol might 232 only bind at the activating site. In contrast to our prediction, in the BiSAS map, the strong 233 continuous density of CI-976 found in the central cavity of the CI-976 bound map was replaced 234 by weak residual densities that were not continuous ( However, the surface representation of the hSOAT1 dimer shows that the reaction chamber is 254 completely shielded from the cytosolic side by the two short αD-αE helices and associated 255 intracellular loops ( Fig. 5e-g ). This suggests that the current structure represents a resting state 256 with relatively low catalytic activity, in which the putative catalytic residue H460 is less 257 accessible to the acyl-CoA substrate (Fig. S11 ). Therefore an activation step that opens the 258 reaction chamber, probably caused by sterol binding at the allosteric activator site, is required for 259 the sterol-dependent fully activation of hSOAT1 4 . 260
The structures of human SOAT1 presented here provide the a high-resolution view of the 261 architecture and domain organization of this important enzyme and shed light on the structure of 262 other closely related MBOAT family proteins, such as SOAT2 and DGAT1. This work not only 263 paves the way towards a better mechanistic understanding of SOAT1-catalyzed reaction, but also 264 provides a template for structure-based inhibitor design to target several human diseases. 
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The cryo-EM map of hSOAT1 tetramer in oval shape, hSOAT1 tetramer in rhombic shape, Purified protein were either directly used for experiments or flash frozen in liquid nitrogen for 358 storage at -80°C. Stored protein was thawed on ice and centrifuged to remove precipitates before 359 further experiments. 360
SOAT1 activity assays using 3 H-oleate in intact cells 361
This assay was designed to measure the rate of 3 H-cholesteryl oleate biosynthesis in intact 362 cells. Mutant CHO AC29 cells that lack endogenous SOAT activity were cultured in 6-well 363 plates at 37 °C and transiently transfected with DNAs from various single amino acid 364 substitutions of hSOAT1 as indicated. Unless stated otherwise, each construct contained the 6x His tag at the N-terminus. We used hSOAT1 that contained the C92A substitution as the "wild 366 type" hSOAT1. Control experiments showed that the SOAT activity of the C92A mutant 367 remained the same as the wild type 21 but the C92A substitution greatly diminished the SOAT1 368 protein aggregation that occurred in vitro during the SDS-PAGE process. 369
At the third day after transfections, the cells were split into three equal parts by 370 trypsinization. One part was used to monitor the hSOAT protein expression by Western blot 371 analysis, using the SOAT1 specific antibodies DM10 as the probe, as described 12 , with the 372 intensity of the WT hSOAT protein set as 1.0. The other two parts of the transfected cells were 373 used to monitor the SOAT enzyme activity, by incubating the intact cells to 20 µl of 3 H-374 oleate/fatty acid free BSA (7.5x 10 6 dpm/µl) for 20 min. The amount of 3 H-cholesteryl oleate 375 produced was determined by the procedure previously described 22, 29 Ecoscint O. The enzyme activity of each mutant hSOAT1 was estimated relative to that of WT 388 hSOAT1, with the protein content of each mutant hSOAT1 normalized with that of the WT 389 hSOAT. 390
SOAT1 activity assay using NBD-cholesterol 391
The mixed micelles with 2.8 mM cholesterol/11.2 mM PC/18.6 mM taurocholate were prepared 392 as described previously 35 . The tetrameric or dimeric hSOAT1 enzyme was prepared in GDN 393 detergent. First, 10 μl 2M KCl, 5μl 5% BSA, 1μl SOAT1 protein (A 280 =0.5), 5 μl micelles, 40 μl 394 TBS buffer with 40 μM GDN were mixed with TBS with 0.5% CHAPS to reach the volume of 395 100 μl and incubated at 37°C for 2 min. In order to measure the IC 50 of inhibitors, different 396 concentrations of given inhibitors were added, as indicated. Then, 1.25 μl 0.2 mg/ml NBD-397 cholesterol (Sigma, N2161) solubilized in 35% β-cyclodextrin (Sigma, HZB1102) was added 398 and the mixture was incubated at 37°C for 2 min. To start the enzymatic reaction, 1 μl 2.5 mM 399 oleoyl-CoA (Sigma, O1012) was added and the reaction mixture was incubated at 37°C for 15 400 min. The reaction was terminated by adding 2:1 chloroform/methanol, the extract was separated 401 on an HPLC column at 0.2 ml/min (Agilent, Poroshell HPH-C18, 2.7 μm) running in 100% 402 ethanol and detected via fluorescence detector on an HPLC (SHIMADZU). NBD-cholesterol 403 eluted at 1.3 min and its ester eluted at 1.9 min. The peak areas of the NBD-cholesteryl ester 404 products and remaining NBD-cholesterol were integrated separately to obtain the relative ratio of 405 NBD-cholesterol that was converted into NBD-cholesteryl esters. 406
Nanodisc preparation 407
MSP2X was constructed by linking two MSP1E3D1 by PCR overlap extension, with Gly-Thr as 408 the linker. The MSP2X gene was constructed into a pET vector, with N-terminal His 6 tag and 409 HRV 3C site. The MSP2X and MSP2N2 proteins were purified as described previously 36 . The 410 eluted SOAT1 protein in TBS buffer with 0.1% digitonin and 10 mM desthiobiotin from strep-tactin column was concentrated by a 100-kDa cut-off ultrafiltration device (Millipore) and 412 exchanged into buffer without desthiobiotin. The SOAT1 protein was mixed with soybean polar 413 lipids extract (SPLE, Avanti) and purified MSP (MSP2N2 for SOAT1 tetramer, MSP2X for 414 SOAT1 dimer) at a molar ratio of SOAT1: MSP: SPLE = 1:7:100. For the hSOAT1 dimer in 415 nanodisc that contained cholesterol, SPLE and cholesterol (at 4:1 ratio) were supplemented in 416 GDN detergent micelles. The SOAT1 protein was mixed with micelles and purified MSP2X at a 417 molar ratio of SOAT1: MSP2X: SPLE = 1:4:100. After incubating at 4°C for 30 min, Bio-beads 418 SM2 (Bio-Rad) were added and rotated at 4°C for 1 h to initiate the reconstitution. Another batch 419 of fresh bio-beads was added and rotated at 4°C overnight. The next day, the Bio-beads were 420 removed and the mixture was loaded into a streptactin column to remove the empty nanodisc. 421
The eluted hSOAT1 in the nanodisc was concentrated and cleaved by prescission protease to 422 remove GFP tags. The nanodisc was centrifuged at 40,000 rpm for 30 min, and then loaded onto 423 a superose-6 increase column running in TBS containing 0.5 mM TCEP. The collected fractions 424 were detected by SDSPAGE and peak fractions were concentrated to A 280 = 1.2. Because the 425 hSOAT1 tended to aggregate after nanodisc reconstitution, fractions of each peak were 426 combined and concentrated for cryo-EM grids preparations and only fractions containing high 427 ratio of SOAT1 dimer were used for data collection. 428
Cryo-EM data collection 429
The nanodisc samples were loaded onto glow-discharged GiG R1/1 holey carbon gold grids 430 (Lantuo) and plunged into liquid ethane by Vitrobot Mark IV (Thermo Fisher Scientific). Cryo-431 grids were screened by Talos Arctica electron microscope (Thermo Fisher Scientific) operated at 432 the voltage of 200 kV using a Ceta 16M camera (Thermo Fisher Scientific). Optimal grids were 433 transferred to Titan Krios electron microscope (Thermo Fisher Scientific) operated at the voltage of 300 kV, with an energy filter set to a slit width of 20 eV. Super-resolution movies (50 frames 435 per movie) were collected with a dose rate of 5.4 e − /pixel/s using K2 Summit direct electron 436 camera (Thermo Fisher Scientific) at a nominal magnification of 130,000 ×, equivalently to a 437 calibrated super-resolution pixel size of 0.5225 Å, and with defocus ranging from -1.3 μm to -2.3 438 μm. All data acquisition was performed automatically using SerialEM 37 . 439
Cryo-EM image processing 440
For the CI-976 complex, super-resolution movie stacks were motion-corrected, dose-weighted 441 and 2-fold binned by MotionCor2 1.1.0 using 9 × 9 patches 38 . Micrographs with ice or ethane 442 contamination were manually removed. Contrast transfer function (CTF) parameters were 443 estimated using Gctf v1.06 39 . Particles were picked by Gautomatch (developed by Kai Zhang) 444 and subjected to reference-free 2D classification. Unless otherwise stated, all classification and 445 reconstruction were performed with Relion 2.0 40 . Initial model was generated by cryoSPARC 41 446 using the selected particles from 2D classification. The selected particles were further subjected 447 to 3D classification using C1 symmetry. The particles selected from good 3D classes were re-448 centered and their local CTF parameters were determined using Gctf v1.06. These particles were 449 further refined by cisTEM 42 using C2 symmetry imposed. The resolution estimation was based 450 on the Part.FSC curve in cisTEM at FSC=0.143 cut-off. Local resolution estimation for hSOAT1 451 dimer and CI-976 complex was calculated using blocres 43 . For the apo state, images were 452 processed in the same way, except the finial refinement were done using Relion 3.0 44 
